NYSE:MLSS

Milestone Scientific (MLSS) Stock Forecast, Price & News

$0.90

-0.02 (-2.17%)

(As of 09/27/2023 ET)

Compare

Today's Range: $0.90
▼
$0.94
50-Day Range: $0.92
▼
$1.31
52-Week Range: $0.41
▼
$1.35

Volume: 51,680 shs
Average Volume: 92,366 shs
Market Capitalization: $64.39 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Milestone Scientific (NYSE:MLSS) Stock

Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. The company also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. In addition, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Further, the company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.

MLSS Price History

30 days | 90 days | 365 days | Advanced Chart

MLSS Stock News Headlines

September 21, 2023 | americanbankingnews.com

StockNews.com Initiates Coverage on Milestone Scientific (NYSE:MLSS)

September 12, 2023 | finance.yahoo.com

Milestone Scientific Appoints Pain Management Industry Veteran Dr. Didier Demesmin to its Board of Directors

September 28, 2023 | Chaikin Analytics (Ad)

Buy This Stock for AI Tidal Wave (not NVDA)

The internet boom made more millionaires than any tech - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.

September 12, 2023 | finance.yahoo.com

Milestone Scientific Appoints Pain Management Industry Veteran Dr. Didier Demesmin to its Board of Directors

August 15, 2023 | msn.com

Milestone Scientific GAAP EPS of -$0.03 misses by $0.01, revenue of $2.9M beats by $0.23M

August 15, 2023 | finance.yahoo.com

Milestone Scientific Achieves 77% Year-Over-Year Increase in Revenue to $2.9 Million for the Second Quarter of 2023

August 12, 2023 | bizjournals.com

SunRail passes 1M annual riders for 1st time since pre-Covid

August 9, 2023 | finance.yahoo.com

Milestone Scientific Schedules Second Quarter 2023 Financial Results and Business Update Conference Call

September 28, 2023 | Chaikin Analytics (Ad)

Buy This Stock for AI Tidal Wave (not NVDA)

The internet boom made more millionaires than any tech - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.

August 9, 2023 | finance.yahoo.com

Milestone Scientific Announces Positive Insurance Payment for the CompuFlo® Epidural System

July 22, 2023 | finanznachrichten.de

LUCY SCIENTIFIC DISCOVERY INC

June 15, 2023 | msn.com

Milestone Scientific: Buy For The $4 Billion Total Addressable Market

June 15, 2023 | finance.yahoo.com

Milestone Scientific to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 20th

June 11, 2023 | msn.com

Milestone Scientific: Sales Could Start To Snowball

May 16, 2023 | finance.yahoo.com

Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within The Pain and Rehabilitation Medical Group in Torrance, California

May 16, 2023 | finance.yahoo.com

Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within The Pain and Rehabilitation Medical Group in Torrance, California

May 12, 2023 | msn.com

Recap: Milestone Scientific Q1 Earnings

May 11, 2023 | finanznachrichten.de

Milestone Scientific, Inc.: Milestone Scientific Achieves Revenue of $2.6 Million and Provides Business Update for the First Quarter of 2023

May 11, 2023 | finance.yahoo.com

Milestone Scientific Achieves Revenue of $2.6 Million and Provides Business Update for the First Quarter of 2023

May 11, 2023 | finance.yahoo.com

Milestone Scientific Achieves Revenue of $2.6 Million and Provides Business Update for the First Quarter of 2023

May 10, 2023 | finance.yahoo.com

Milestone Scientific Announces Successful Epidural Steroid Injection Procedures Under New AMA CPT Guidelines for Artificial Intelligence (AI) Assisted Pain Management Surgery

May 9, 2023 | finance.yahoo.com

Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within the Sports and Spine Clinic in Oregon

May 5, 2023 | finance.yahoo.com

Milestone Scientific Schedules First Quarter 2023 Financial Results and Business Update Conference Call

April 4, 2023 | markets.businessinsider.com

Maxim Group Reaffirms Their Buy Rating on Milestone Scientific (MLSS)

April 4, 2023 | finance.yahoo.com

Milestone Scientific Inc. (AMEX:MLSS) Q4 2022 Earnings Call Transcript

March 31, 2023 | finanznachrichten.de

Milestone Scientific, Inc.: Milestone Scientific Provides 2022 Year-End Business Update

March 31, 2023 | finance.yahoo.com

Milestone Scientific Provides 2022 Year-End Business Update

See More Headlines

Receive MLSS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Milestone Scientific and its competitors with MarketBeat's FREE daily newsletter.

MLSS Company Calendar

Last Earnings: 8/15/2023
Today: 9/27/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Surgical appliances & supplies
Sub-Industry: N/A
Sector: Medical
Current Symbol: NYSE:MLSS
CUSIP: N/A
CIK: 855683
Web: www.milestonescientific.com
Phone: (973) 535-2717
Fax: 973-535-2829
Employees: 20
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.10)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-8,710,000.00
Net Margins: -74.96%
Pretax Margin: -75.47%
Return on Equity: -78.34%
Return on Assets: -57.02%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 3.38
Quick Ratio: 2.67

Sales & Book Value

Annual Sales: $9.96 million
Price / Sales: 6.73
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $0.15 per share
Price / Book: 6.27

Miscellaneous

Outstanding Shares: 71,366,000
Free Float: 53,382,000
Market Cap: $67.08 million
Optionable: Optionable
Beta: 1.32

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

Mr. Jan Adriaan Haverhals (Age 61)
Pres, CEO & Director
Comp: $624.76k

Mr. Leonard A. Osser (Age 76)
Founder, MD of China Operations & Director

Mr. Andy Molnar (Age 61)
Sr. VP of Global Sales & Bus. Devel. for Dental

Keisha Harcum
Controller

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

MLSS Stock - Frequently Asked Questions

How have MLSS shares performed in 2023?: Milestone Scientific's stock was trading at $0.48 on January 1st, 2023. Since then, MLSS shares have increased by 95.8% and is now trading at $0.9399.
View the best growth stocks for 2023 here.
How were Milestone Scientific's earnings last quarter?: Milestone Scientific Inc. (NYSE:MLSS) issued its quarterly earnings results on Tuesday, August, 15th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.02) by $0.01. The company had revenue of $2.91 million for the quarter. Milestone Scientific had a negative net margin of 74.96% and a negative trailing twelve-month return on equity of 78.34%.
What other stocks do shareholders of Milestone Scientific own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Milestone Scientific investors own include AcelRx Pharmaceuticals (ACRX), Aptinyx (APTX), Axcella Health (AXLA), Aytu BioPharma (AYTU), Calithera Biosciences (CALA), Cidara Therapeutics (CDTX), Catalyst Pharmaceuticals (CPRX), DURECT (DRRX), Geron (GERN) and
What is Milestone Scientific's stock symbol?: Milestone Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "MLSS."

Who are Milestone Scientific's major shareholders?: Milestone Scientific's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Geode Capital Management LLC (0.59%), Northern Trust Corp (0.14%), BlackRock Inc. (0.13%), Charles Schwab Investment Management Inc. (0.05%) and Simplex Trading LLC (0.00%). Insiders that own company stock include Giandomenico Trombetta, Joseph D'agostino, Leonard Osser, Leslie Bernhard and Neal I Goldman.
View institutional ownership trends.
How do I buy shares of Milestone Scientific?: Shares of MLSS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Milestone Scientific's stock price today?: One share of MLSS stock can currently be purchased for approximately $0.94.
How much money does Milestone Scientific make?: Milestone Scientific (NYSE:MLSS) has a market capitalization of $67.08 million and generates $9.96 million in revenue each year. The company earns $-8,710,000.00 in net income (profit) each year or ($0.10) on an earnings per share basis.
How can I contact Milestone Scientific?: Milestone Scientific's mailing address is 425 Eagle Rock Avenue Suite 403, Roseland NJ, 07068. The official website for the company is www.milestonescientific.com. The company can be reached via phone at (973) 535-2717, via email at mlss@crescendo-ir.com, or via fax at 973-535-2829.

This page (NYSE:MLSS) was last updated on 9/28/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial